Human Vaccine Trials For New Coronavirus Could Begin In 3 Months; Virus Yet To Be Named

The Hill: Coronavirus vaccine could begin human trials in three months
“A top official at the National Institutes of Health (NIH) said Wednesday that human trials for a vaccine to counter a new strain of coronavirus behind an outbreak of viral pneumonia in China could begin within three months…” (Bowden, 1/22).

STAT: It’s been sequenced. It’s spread across borders. Now the new pneumonia-causing virus needs a name
“…The pneumonia-causing virus, which is spreading rapidly in China and beyond, is currently being identified as 2019-nCoV, shorthand for a novel or new (i.e. ‘n’) coronavirus (CoV) that was first detected in 2019. The disease it causes doesn’t yet have a name, either, though Wuhan SARS or Wu Flu are among of the options being thrown around on the internet…” (Branswell, 1/23).

Additional coverage of what is known about the novel coronavirus is available from AP, Global Health NOW, New York Times (2), PBS NewsHour, Scientific American, STAT, and Washington Post (2).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.